Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
11°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
99
100
Next >
Alignment with FDA on Pediatric Study Plan and Accelerated Approval to Treat Bipolar Depression and Akathisia: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
July 30, 2024
Via
Get News
Exposures
Product Safety
Tickers
NRXP
FDA Warns Of Overdose Risks With Compounded Wegovy, Ozempic Injections
July 30, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
NVO
Acarix announces shares are now being traded on the OTCQB under the ticker ACIXF
July 30, 2024
Via
News Direct
Exposures
Product Safety
Family Vision Optical Welcomes Dr. Amanda Bancroft to Their Eye Care Team
July 30, 2024
Via
Press Advantage
Topics
Product Recall
Exposures
Legal
Product Safety
TSLA Stock Drops as Tesla Recalls 1.8 Million EVs Over Hood Issue
July 30, 2024
Via
InvestorPlace
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
DAL
SA
SOFI
TSLA
InvestorNewsBreaks – Processa Pharmaceuticals Inc.’s (NASDAQ: PCSA) IND Application for Phase 2 Clinical Trial of NGC-Cap in Patients with Breast Cancer Receives FDA Clearance
July 30, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
PCSA
Movano Evie Ring Could Soon Get FDA Clearance, Analyst Says: 'A Validated Wearable Device Truly Opens The Market'
July 30, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
MOVE
Annovis Bio Inc. (NYSE: ANVS) Announces FDA Approval to Transition to New Form of Buntanetap for Future Clinical Trials
July 30, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
ANVS
Merck's Q2 Earnings: Revenue And EPS Beat Helped By Strong Keytruda Sales, But Acquisition Costs Bites Into Annual Profit Forecast
July 30, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
DSKYF
DSNKY
MRK
Tesla Recalls Over 1.8M Vehicles Over Concerns Of Unlatched Hood Opening When Driving
July 30, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
TSLA
Art Installation Near White House Urges FDA To Approve MDMA-Assisted Therapy For Veterans As Decision Time Looms
July 29, 2024
Via
Benzinga
Exposures
Product Safety
FDA Greenlights Guardant Health's Shield Blood Test, Analyst Cautious on Adoption
July 29, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
EXAS
GH
FDA Puts Brake On vTv Therapeutics' Diabetes Candidate Program, Including Late-Stage Study, Stock Tanks
July 29, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
VTVT
American Kratom Association Calls on the FDA To Be Fully Transparent and Accountable in Their Safety Alert on Kratom Products
July 29, 2024
Via
EZ Newswire
Exposures
Product Safety
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Lomecel-B(TM) Study Results Presented at the Alzheimer’s Association International Conference
July 29, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
LGVN
AGC Biologics’ Seattle Site Achieves Successful Multi-Product Inspection by U.S. Food and Drug Administration for Biologics License Applications
July 29, 2024
Via
News Direct
Exposures
Product Safety
Therma Bright's Venowave VW5 Secures FDA 510K Approval
July 29, 2024
Via
Newsfile
Exposures
Product Safety
Tickers
TBRIF
TSX-V:THRM
Maningas Cosmetic Surgery Introduces Weight Loss Injections with Semaglutide & Tirzepatide to Joplin Practice
July 26, 2024
Via
Press Advantage
Exposures
Product Safety
Produce Recalls 2024: Kroger, Aldi, Walmart Pull Veggies From Shelves
July 26, 2024
Via
InvestorPlace
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
KR
WMT
Cheese Recalls 2024: St. Jerome Cheese Recalled Due to Possible Health Risks
July 26, 2024
Via
InvestorPlace
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
ACI
KR
Loretta Mester, Former President & CEO of Cleveland Fed, Available for Speaking Engagements
July 25, 2024
Via
PRLog
Topics
Economy
Exposures
Interest Rates
Product Safety
Wisconsin Vein Center & MediSpa Introduces Revolutionary Sofwave Treatment in Milwaukee
July 25, 2024
Via
GetFeatured
Exposures
Product Safety
PaxMedica Inc. (NASDAQ: PXMD) Developing Treatments for Underserved Neurological Disorders
July 25, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
PXMD
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected
July 25, 2024
Via
FinancialNewsMedia
Exposures
Product Safety
Tickers
ABBV
AXSM
LLY
PFE
Food Processing Company Stock Gets Fried by Recall: Time to Buy
July 24, 2024
Via
MarketBeat
Topics
Product Recall
Supply Chain
Exposures
Legal
Product Safety
Supply Chain
Tickers
LW
MCD
XLP
Top Realtor in Phoenix, AZ, Celebrates Over Two Decades of Multilingual Real Estate Excellence
July 24, 2024
Via
AB Newswire
Topics
Product Recall
Exposures
Legal
Product Safety
Nadrich Accident Injury Lawyers Urges FDA to Ban Formaldehyde in Hair Relaxers
July 24, 2024
Via
PRUnderground
Exposures
Product Safety
Pharma Giant Johnson & Johnson Asks FDA To Approve Esketamine Nasal Spray For Treatment-Resistant Depression
July 23, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
JNJ
MAIA Biotechnology (MAIA) is one of the earliest pioneers of telomere targeting as a therapeutic strategy
July 23, 2024
Via
AB Newswire
Exposures
Product Safety
Tickers
MAIA
Creative Diagnostics Launches Comprehensive Host Cell DNA Assay Kits for Bioprocess Impurity Analysis
July 23, 2024
Via
AB Newswire
Topics
Supply Chain
Exposures
Product Safety
Supply Chain
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.